Idrocilamide: Difference between revisions
Appearance
Content deleted Content added
mNo edit summary |
Entranced98 (talk | contribs) Adding local short description: "Muscle relaxant", overriding Wikidata description "Skeletal Muscle Relaxant" |
||
(34 intermediate revisions by 25 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Muscle relaxant}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
| verifiedrevid = 447822894 |
|||
| image = |
|||
| IUPAC_name = ''N''-(2-Hydroxyethyl)-3-phenyl-2-propenamide, N-(2 hydroxyethyl)cinnamamide |
|||
⚫ | |||
| width = |
| width = |
||
| alt = |
| alt = |
||
Line 8: | Line 12: | ||
| width2 = |
| width2 = |
||
| alt2 = |
| alt2 = |
||
| |
| caption = |
||
| drug_name = <!-- else may use imagename --> |
|||
| caption = |
|||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = Talval, Srilane, Relaxnova, Brolitène |
||
| Drugs.com = |
| Drugs.com = {{Drugs.com|international|idrocilamide}} |
||
| MedlinePlus = |
| MedlinePlus = |
||
| licence_EU = <!-- EMA requires brand name --> |
| licence_EU = <!-- EMA requires brand name --> |
||
Line 28: | Line 30: | ||
| legal_status = |
| legal_status = |
||
| dependency_liability = |
| dependency_liability = |
||
| routes_of_administration = |
| routes_of_administration = [[Topical]] |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
Line 35: | Line 37: | ||
| metabolism = |
| metabolism = |
||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| CAS_number = 6961-46-2 |
| CAS_number = 6961-46-2 |
||
| CAS_supplemental = |
| CAS_supplemental = |
||
Line 44: | Line 47: | ||
| ATC_suffix = AX05 |
| ATC_suffix = AX05 |
||
| ATC_supplemental = |
| ATC_supplemental = |
||
| PubChem = |
| PubChem = 1550874 |
||
| PubChemSubstance = |
| PubChemSubstance = |
||
| IUPHAR_ligand = |
| IUPHAR_ligand = |
||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|||
| DrugBank = |
| DrugBank = |
||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ChemSpiderID |
| ChemSpiderID = 1267352 |
||
| UNII = |
|||
| smiles = O=C(\C=C\c1ccccc1)NCCO |
|||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChI = 1S/C11H13NO2/c13-9-8-12-11(14)7-6-10-4-2-1-3-5-10/h1-7,13H,8-9H2,(H,12,14)/b7-6+ |
|||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChIKey = OSCTXCOERRNGLW-VOTSOKGWSA-N |
|||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = 6C816LUB1O |
|||
| KEGG_Ref = {{keggcite|correct|kegg}} |
|||
| KEGG = |
| KEGG = |
||
| ChEBI_Ref = {{ebicite|correct|EBI}} |
|||
| ChEBI = |
| ChEBI = |
||
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|||
| ChEMBL = |
|||
⚫ | |||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=11 | H=13 | N=1 | O=2 |
| C=11 | H=13 | N=1 | O=2 |
||
| molecular_weight = 191 |
|||
| smiles = |
|||
| StdInChI = |
|||
| StdInChI_comment = |
|||
| StdInChIKey = |
|||
| synonyms = |
| synonyms = |
||
| density = |
| density = |
||
Line 73: | Line 82: | ||
}} |
}} |
||
'''Idrocilamide''' (''' |
'''Idrocilamide''' (trade names '''Talval''', '''Srilane''', '''Relaxnova''', '''Brolitène'''<ref name="Drugs.com">Drugs.com: {{Drugs.com|international|idrocilamide}}</ref>) is a [[medication]] with skeletal muscle relaxant<ref> |
||
{{Cite journal |
|||
|vauthors=Bouron A, Rivet M, Nasri-Sebdani M, Guillemain J, Durbin P, Guerrier D, Raymond G |
|||
|year=1990 |
|||
|title=The direct depressant effect of LCB29 (idrocilamide) on mechanical tension of rat soleus muscle fibers |
|||
|journal=[[Canadian Journal of Physiology and Pharmacology]] |
|||
|volume=68 |issue=12 |pages=1503–1509 |
|||
|doi=10.1139/y90-228 |
|||
|pmid=2085796 |
|||
}}</ref> and anti-inflammatory actions<ref name=pmid8012322> |
|||
{{cite journal |
|||
|vauthors=Bannwarth B, Le Huec JC, Vinçon G, Labat L, Demotes-Mainard F, Rivaille F, Le Rebeller A |
|||
|year=1993 |
|||
|title=[Tissue and systemic diffusion of idrocilamide after cutaneous administration] |
|||
|language=French |
|||
|journal=[[Revue du Rhumatisme]] |
|||
|volume=60 |issue=12 |pages=932–6 |
|||
|pmid=8012322 |
|||
|doi= |
|||
}}</ref> used as a topical cream to treat [[lumbago]] and other kinds of [[myalgia|muscular pain]];<ref> |
|||
{{Cite journal |
|||
|vauthors=Stehman M, Lehert P |
|||
|year=1990 |
|||
|title=Clinical double-blind study with idrocilamide ointment in the treatment of acute lumbago |
|||
|journal=[[Acta Belgica. Medica Physica]] |
|||
|volume=13 |issue=1 |pages=29–32 |
|||
|pmid=2140002 |
|||
}}</ref> it is available on prescription or over-the-counter{{citation needed|date=June 2012}} in France and various other countries.<ref name="Drugs.com" /> |
|||
==Interactions== |
|||
Idrocilamide has been reported to be a potent inhibitor of the metabolism of caffeine.<ref name=pmid10976659> |
|||
{{cite journal |
|||
|vauthors=Carrillo JA, Benitez J |
|||
|year=2000 |
|||
|title=Clinically significant pharmacokinetic interactions between dietary caffeine and medications |
|||
|journal=[[Clinical Pharmacokinetics]] |
|||
|volume=39 |issue=2 |pages=127–53 |
|||
|doi=10.2165/00003088-200039020-00004 |
|||
|pmid=10976659 |
|||
}}</ref><ref name=pmid7371698> |
|||
{{cite journal |
|||
|vauthors=Brazier JL, Descotes J, Lery N, Ollagnier M, Evreux JC |
|||
|date=1980 |
|||
|title=Inhibition by idrocilamide of the disposition of caffeine |
|||
|journal=[[European Journal of Clinical Pharmacology]] |
|||
|volume=17 |issue=1 |pages=37–43 |
|||
|doi=10.1007/bf00561675 |
|||
|pmid=7371698 |
|||
}}</ref> |
|||
==References== |
|||
{{reflist}} |
|||
{{Topical products for joint and muscular pain}} |
|||
[[Category:Drugs acting on the musculoskeletal system]] |
|||
⚫ | |||
{{Musculoskeletal-drug-stub}} |
|||
⚫ |
Latest revision as of 15:08, 31 January 2023
Clinical data | |
---|---|
Trade names | Talval, Srilane, Relaxnova, Brolitène |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Topical |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.027.414 |
Chemical and physical data | |
Formula | C11H13NO2 |
Molar mass | 191.230 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Idrocilamide (trade names Talval, Srilane, Relaxnova, Brolitène[1]) is a medication with skeletal muscle relaxant[2] and anti-inflammatory actions[3] used as a topical cream to treat lumbago and other kinds of muscular pain;[4] it is available on prescription or over-the-counter[citation needed] in France and various other countries.[1]
Interactions
[edit]Idrocilamide has been reported to be a potent inhibitor of the metabolism of caffeine.[5][6]
References
[edit]- ^ a b Drugs.com: International Drug Names
- ^ Bouron A, Rivet M, Nasri-Sebdani M, Guillemain J, Durbin P, Guerrier D, Raymond G (1990). "The direct depressant effect of LCB29 (idrocilamide) on mechanical tension of rat soleus muscle fibers". Canadian Journal of Physiology and Pharmacology. 68 (12): 1503–1509. doi:10.1139/y90-228. PMID 2085796.
- ^ Bannwarth B, Le Huec JC, Vinçon G, Labat L, Demotes-Mainard F, Rivaille F, Le Rebeller A (1993). "[Tissue and systemic diffusion of idrocilamide after cutaneous administration]". Revue du Rhumatisme (in French). 60 (12): 932–6. PMID 8012322.
- ^ Stehman M, Lehert P (1990). "Clinical double-blind study with idrocilamide ointment in the treatment of acute lumbago". Acta Belgica. Medica Physica. 13 (1): 29–32. PMID 2140002.
- ^ Carrillo JA, Benitez J (2000). "Clinically significant pharmacokinetic interactions between dietary caffeine and medications". Clinical Pharmacokinetics. 39 (2): 127–53. doi:10.2165/00003088-200039020-00004. PMID 10976659.
- ^ Brazier JL, Descotes J, Lery N, Ollagnier M, Evreux JC (1980). "Inhibition by idrocilamide of the disposition of caffeine". European Journal of Clinical Pharmacology. 17 (1): 37–43. doi:10.1007/bf00561675. PMID 7371698.